KLTO
Price
$1.14
Change
-$0.05 (-4.20%)
Updated
Jul 3 closing price
Capitalization
41.6M
SLXN
Price
$0.81
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
7.05M
Interact to see
Advertisement

KLTO vs SLXN

Header iconKLTO vs SLXN Comparison
Open Charts KLTO vs SLXNBanner chart's image
Klotho Neurosciences
Price$1.14
Change-$0.05 (-4.20%)
Volume$4.22M
Capitalization41.6M
Silexion Therapeutics
Price$0.81
Change-$0.00 (-0.00%)
Volume$107K
Capitalization7.05M
KLTO vs SLXN Comparison Chart in %
Loading...
KLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KLTO vs. SLXN commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KLTO is a Buy and SLXN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (KLTO: $1.14 vs. SLXN: $0.81)
Brand notoriety: KLTO and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KLTO: 13% vs. SLXN: 17%
Market capitalization -- KLTO: $41.6M vs. SLXN: $7.05M
KLTO [@Biotechnology] is valued at $41.6M. SLXN’s [@Biotechnology] market capitalization is $7.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KLTO’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • KLTO’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, both KLTO and SLXN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KLTO’s TA Score shows that 6 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • KLTO’s TA Score: 6 bullish, 4 bearish.
  • SLXN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, KLTO is a better buy in the short-term than SLXN.

Price Growth

KLTO (@Biotechnology) experienced а -8.80% price change this week, while SLXN (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KLTO($41.6M) has a higher market cap than SLXN($7.05M). KLTO YTD gains are higher at: 135.052 vs. SLXN (-59.652). KLTO has higher annual earnings (EBITDA): -6.8M vs. SLXN (-16.96M). SLXN has more cash in the bank: 6.15M vs. KLTO (566K). KLTO has less debt than SLXN: KLTO (1.77M) vs SLXN (3.48M). KLTO (0) and SLXN (0) have equivalent revenues.
KLTOSLXNKLTO / SLXN
Capitalization41.6M7.05M590%
EBITDA-6.8M-16.96M40%
Gain YTD135.052-59.652-226%
P/E RatioN/AN/A-
Revenue00-
Total Cash566K6.15M9%
Total Debt1.77M3.48M51%
TECHNICAL ANALYSIS
Technical Analysis
KLTOSLXN
RSI
ODDS (%)
Bearish Trend 4 days ago
12%
Bullish Trend 4 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
36%
Bullish Trend 4 days ago
41%
Momentum
ODDS (%)
Bearish Trend 4 days ago
63%
Bearish Trend 4 days ago
17%
MACD
ODDS (%)
Bearish Trend 4 days ago
38%
Bearish Trend 4 days ago
15%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
68%
Bullish Trend 4 days ago
26%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
25%
Bearish Trend 4 days ago
48%
Advances
ODDS (%)
Bullish Trend 27 days ago
60%
Bullish Trend 4 days ago
51%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 20 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
36%
Aroon
ODDS (%)
Bullish Trend 4 days ago
17%
Bearish Trend 4 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
KLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YHC1.910.30
+18.63%
LQR House Inc
MCRB11.871.01
+9.30%
Seres Therapeutics Inc
WWD252.343.52
+1.41%
Woodward
EXK5.08N/A
N/A
Endeavour Silver Corp
XENE33.26-0.11
-0.33%
Xenon Pharmaceuticals

KLTO and

Correlation & Price change

A.I.dvisor tells us that KLTO and CTXR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KLTO and CTXR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLTO
1D Price
Change %
KLTO100%
-4.20%
CTXR - KLTO
32%
Poorly correlated
+5.24%
ANIX - KLTO
31%
Poorly correlated
+1.25%
TAOX - KLTO
29%
Poorly correlated
+5.20%
KALA - KLTO
27%
Poorly correlated
+0.99%
GUTS - KLTO
27%
Poorly correlated
+0.61%
More

SLXN and

Correlation & Price change

A.I.dvisor tells us that SLXN and CHRS have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SLXN and CHRS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
+0.70%
CHRS - SLXN
24%
Poorly correlated
+1.87%
FBRX - SLXN
23%
Poorly correlated
-1.30%
ORIC - SLXN
20%
Poorly correlated
+1.41%
CTNM - SLXN
9%
Poorly correlated
-3.00%
KLTO - SLXN
7%
Poorly correlated
-4.20%
More